Which International ETF Is the Better Buy: Schwab's Emerging Markets SCHE or iShares' World ETF URTH?

Schwab Emerging Markets Equity ETF (SCHE) is presented as the better value versus iShares MSCI World ETF (URTH), with a 0.06% expense ratio versus 0.24% and a 2.6% trailing-12-month yield versus 1.4%. URTH delivered stronger five-year growth ($1,723 versus $1,391 per $1,000 invested) and a smaller maximum drawdown of 26.1% versus 31.4%, but more than 60% of its portfolio is invested in U.S. equities. Both funds have roughly 30% technology exposure, while SCHE provides broader direct exposure to emerging-market companies and carries greater political, currency, and regulatory risk.

Analysis

The relevant allocation decision is not emerging markets versus developed markets broadly; it is a concentrated semiconductor/China-internet factor versus an already-owned U.S. mega-cap technology factor. SCHE's unusually large TSM exposure makes its near-term return path more sensitive to AI-capex demand, Taiwan risk premia, and the USD/TWD than to broad EM domestic growth. URTH is a less efficient diversifier for U.S.-based portfolios because its largest exposures overlap materially with S&P 500 and Nasdaq ownership; incremental URTH flows likely reinforce, rather than diversify, existing NVDA/AAPL/MSFT factor risk.

Over 1-3 months, a weaker dollar, improving China policy expectations, or upward TSM revenue revisions would favor SCHE relative to URTH. The principal falsifier is a deterioration in TSM's monthly sales/forward guidance, renewed Taiwan Strait risk, or a stronger-dollar/rising-real-yield regime, each of which can overwhelm EM valuation support. Over 6-18 months, the key structural question is whether China internet monetization and semiconductor supply-chain localization offset persistent geopolitical discounts; the headline fee differential alone is not a catalyst, and is economically immaterial to SCHW's earnings base.

Consensus appears to treat low-volatility, developed-market exposure as defensive. But URTH's effective beta in an AI-led drawdown may be higher than its historical fund beta implies because its technology concentration is correlated with the same crowded leadership that dominates domestic benchmarks. Conversely, SCHE's index-level diversification masks a single-name Taiwan semiconductor tail risk; it should be sized as an active TSM/Asia-tech allocation, not as a generic EM core holding.

Key Decisions for Investors

• No standalone SCHW trade: ETF fee revenue on this product is too small to create a measurable earnings catalyst. Monitor only if Schwab reports broad ETF share gains or material net-new asset flows.
• For portfolios already overweight NVDA, AAPL, and MSFT, avoid adding URTH as an international-diversification sleeve over the next 1-3 months; use a non-U.S./ex-U.S. vehicle instead if diversification is the objective.
• Conditional relative-value trade: long SCHE / short URTH only after confirmation of a softer USD and positive TSM monthly-sales or guidance momentum. Target a 5-8% relative move over 3-6 months; exit if TSM revises capex or revenue expectations downward, or if Taiwan geopolitical risk materially widens regional equity risk premia.
• If seeking EM upside with defined tail risk, use a modest SCHE position paired with downside protection through TSM puts or a Taiwan/semiconductor hedge. The hedge is warranted because index diversification does not neutralize SCHE's dominant single-company exposure.